Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Inicio Conocimiento Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

The aim of this study was to compare the humoral immune response provided by four commercialised reproductive vaccines against swine erysipelas (SE) and porcine parvovirus (PPV), under field conditions in Denmark. 

Sobre este artículo

Apareció en

European Symposium of Porcine Health Management, 2018

Fecha

10 jul. 2018

Autores

Pedersen, K.S.; Camprodon, A.; Llopart, D.; Jorda, R.; Strunz, A.M.

Resumen

Gilts vaccinated with ERYSENG® PARVO exhibited the highest serological response compared with animals vaccinated with one of the other three commercialised vaccines against E. rhusiopathiae.

Productos relacionados

Compartir en